BioShield is a U.S. government initiative that finances the stockpiling of drugs and vaccines against bioterror agents. A survey of 30 experts in biomedical research or drug and vaccine development, however, indicates that BioShield doesn't do enough to engage the private sector. A summary of the study, performed by the Sarnoff Corporation and the Center for Biosecurity of the University of Pittsburgh Medical Center, can be found below.

bioshield0305.pdf

.